Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysis

S. Camera, A. Vogel, M. Rimini, M. Ikeda, O. Abidoye, J. Lucchetti, L. Antonuzzo, J.W. Kim, F. Nichetti, A. Saborowski, T. Pressiani, C. Vivaldi, I.G. Rapposelli, F. Peeters, C. Braconi, D.J. Pinato, E. Tamburini, C. Pircher, S. Tamberi, F. Castet, M. Verrico, A. Parisi, N. Couto, H.J. Chon, A. Martirena, A. Lamarca, M. Landriscina, F. Finkelmeier, E. Oneda, A. Avallone, E. Dell’Aquila, L. Perkhofer, I.H. Kim, V. Formica, C.M. de Sousa Pinto, I. Garajova, B. Kang, S. Corallo, E. Fenocchio, G. Farinea, A. Pastorino, A. Diana, Y. Changhoon, M. Schirripa, M.G. Rodriquenz, M. Scartozzi, L. Zumstein, M. Ghidini, G.W. Prager, G. Aprile, G.P. Spinelli, S. Yung-Yeh, S.L. Chan, E. Warmington, A. Lancianese, T. Satake, T. Bekaii-Saab, G. Giordano, D. Lavacchi, L. Passeri, M. Ferrara, F. Rossari, F. Lo Prinzi, M. Kang, A.A. Prete, S. Bozzarelli, M. Persano, G. Masi, R. Balsano, M. Niger, S. Lonardi, F. Salani, L. Fornaro, L. Rimassa, A. Casadei-Gardini

Open source

DOI
10.1016/j.esmoop.2026.108248
Published
2026-07
Container
ESMO Open
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.esmoop.2026.108248,
  title = {Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysis},
  author = {S. Camera and A. Vogel and M. Rimini and M. Ikeda and O. Abidoye and J. Lucchetti and L. Antonuzzo and J.W. Kim and F. Nichetti and A. Saborowski and T. Pressiani and C. Vivaldi and I.G. Rapposelli and F. Peeters and C. Braconi and D.J. Pinato and E. Tamburini and C. Pircher and S. Tamberi and F. Castet and M. Verrico and A. Parisi and N. Couto and H.J. Chon and A. Martirena and A. Lamarca and M. Landriscina and F. Finkelmeier and E. Oneda and A. Avallone and E. Dell’Aquila and L. Perkhofer and I.H. Kim and V. Formica and C.M. de Sousa Pinto and I. Garajova and B. Kang and S. Corallo and E. Fenocchio and G. Farinea and A. Pastorino and A. Diana and Y. Changhoon and M. Schirripa and M.G. Rodriquenz and M. Scartozzi and L. Zumstein and M. Ghidini and G.W. Prager and G. Aprile and G.P. Spinelli and S. Yung-Yeh and S.L. Chan and E. Warmington and A. Lancianese and T. Satake and T. Bekaii-Saab and G. Giordano and D. Lavacchi and L. Passeri and M. Ferrara and F. Rossari and F. Lo Prinzi and M. Kang and A.A. Prete and S. Bozzarelli and M. Persano and G. Masi and R. Balsano and M. Niger and S. Lonardi and F. Salani and L. Fornaro and L. Rimassa and A. Casadei-Gardini},
  year = {2026},
  journal = {ESMO Open},
  doi = {10.1016/j.esmoop.2026.108248},
  url = {https://doi.org/10.1016/j.esmoop.2026.108248}
}

RIS

TY  - JOUR
TI  - Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysis
AU  - S. Camera
AU  - A. Vogel
AU  - M. Rimini
AU  - M. Ikeda
AU  - O. Abidoye
AU  - J. Lucchetti
AU  - L. Antonuzzo
AU  - J.W. Kim
AU  - F. Nichetti
AU  - A. Saborowski
AU  - T. Pressiani
AU  - C. Vivaldi
AU  - I.G. Rapposelli
AU  - F. Peeters
AU  - C. Braconi
AU  - D.J. Pinato
AU  - E. Tamburini
AU  - C. Pircher
AU  - S. Tamberi
AU  - F. Castet
AU  - M. Verrico
AU  - A. Parisi
AU  - N. Couto
AU  - H.J. Chon
AU  - A. Martirena
AU  - A. Lamarca
AU  - M. Landriscina
AU  - F. Finkelmeier
AU  - E. Oneda
AU  - A. Avallone
AU  - E. Dell’Aquila
AU  - L. Perkhofer
AU  - I.H. Kim
AU  - V. Formica
AU  - C.M. de Sousa Pinto
AU  - I. Garajova
AU  - B. Kang
AU  - S. Corallo
AU  - E. Fenocchio
AU  - G. Farinea
AU  - A. Pastorino
AU  - A. Diana
AU  - Y. Changhoon
AU  - M. Schirripa
AU  - M.G. Rodriquenz
AU  - M. Scartozzi
AU  - L. Zumstein
AU  - M. Ghidini
AU  - G.W. Prager
AU  - G. Aprile
AU  - G.P. Spinelli
AU  - S. Yung-Yeh
AU  - S.L. Chan
AU  - E. Warmington
AU  - A. Lancianese
AU  - T. Satake
AU  - T. Bekaii-Saab
AU  - G. Giordano
AU  - D. Lavacchi
AU  - L. Passeri
AU  - M. Ferrara
AU  - F. Rossari
AU  - F. Lo Prinzi
AU  - M. Kang
AU  - A.A. Prete
AU  - S. Bozzarelli
AU  - M. Persano
AU  - G. Masi
AU  - R. Balsano
AU  - M. Niger
AU  - S. Lonardi
AU  - F. Salani
AU  - L. Fornaro
AU  - L. Rimassa
AU  - A. Casadei-Gardini
PY  - 2026
JO  - ESMO Open
DO  - 10.1016/j.esmoop.2026.108248
UR  - https://doi.org/10.1016/j.esmoop.2026.108248
ER  - 

APA

Camera, S., Vogel, A., Rimini, M., Ikeda, M., Abidoye, O., Lucchetti, J., Antonuzzo, L., Kim, J., Nichetti, F., Saborowski, A., Pressiani, T., Vivaldi, C., Rapposelli, I., Peeters, F., Braconi, C., Pinato, D., Tamburini, E., Pircher, C., Tamberi, S., Castet, F., Verrico, M., Parisi, A., Couto, N., Chon, H., Martirena, A., Lamarca, A., Landriscina, M., Finkelmeier, F., Oneda, E., Avallone, A., Dell’Aquila, E., Perkhofer, L., Kim, I., Formica, V., Pinto, C. D. S., Garajova, I., Kang, B., Corallo, S., Fenocchio, E., Farinea, G., Pastorino, A., Diana, A., Changhoon, Y., Schirripa, M., Rodriquenz, M., Scartozzi, M., Zumstein, L., Ghidini, M., Prager, G., Aprile, G., Spinelli, G., Yung-Yeh, S., Chan, S., Warmington, E., Lancianese, A., Satake, T., Bekaii-Saab, T., Giordano, G., Lavacchi, D., Passeri, L., Ferrara, M., Rossari, F., Prinzi, F. L., Kang, M., Prete, A., Bozzarelli, S., Persano, M., Masi, G., Balsano, R., Niger, M., Lonardi, S., Salani, F., Fornaro, L., Rimassa, L., & Casadei-Gardini, A. (2026). Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysis. ESMO Open. https://doi.org/10.1016/j.esmoop.2026.108248

Source records